AIM
TAK icon

Axiom Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

Axiom Investment Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-289
Closed -$4K – 398
2022
Q3 		$4K Buy
+289
New +$4.02K 0.01% 307
2019
Q3 		– Sell
-10,639
Closed -$190K – 390
2019
Q2 		$190K Buy
10,639
+371
+4% +$6.75K 0.03% 359
2019
Q1 		$209K Buy
+10,268
New +$207K 0.04% 337

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Axiom Investment Management's TAK Position: Q4 2022 in Review

Axiom Investment Management sold out of Takeda Pharmaceutical (TAK) in Q4 2022, closing a stake of 289 shares — an estimated $4K sold.

Axiom Investment Management first reported a position in TAK in Q1 2019 and held it in 3 quarters. The position peaked at $209K in Q1 2019. 281 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

  • Axiom Investment Management reported no remaining Takeda Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Axiom Investment Management sold 289 Takeda Pharmaceutical shares in Q4 2022, an estimated $4K.
  • Axiom Investment Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 3 quarters.
  • Axiom Investment Management's Takeda Pharmaceutical position peaked at $209K in Q1 2019.
  • 281 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on Axiom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.